Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-03-09

FDA Approved: DEFERASIROX ORAL GRANULES — Original Application (EPIC PHARMA, LLC)

View source ↗

Summary

FDA approved Deferasirox oral granules as an original generic application for treating chronic iron overload due to transfusion in patients 2 years of age and o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Deferasirox Oral Granules (DEFERASIROX)

Snippet

ORIG AP for DEFERASIROX ORAL GRANULES (DEFERASIROX)